Y. Chan, C. Siu, K. Yiu, Sw Li, S. Tam, Th Lam, C. Lau, H. Tse, N. Smeeton, S. Allender, S. Yamada, K. Kamisaka, A. Araki, Y. Fujioka, K. Yasui, Y. Hasegawa, Koike
{"title":"海报会议四:流行病学和公共卫生","authors":"Y. Chan, C. Siu, K. Yiu, Sw Li, S. Tam, Th Lam, C. Lau, H. Tse, N. Smeeton, S. Allender, S. Yamada, K. Kamisaka, A. Araki, Y. Fujioka, K. Yasui, Y. Hasegawa, Koike","doi":"10.1177/17418267100170s230","DOIUrl":null,"url":null,"abstract":"P475 Secondary prevention of stroke in Czech patients in the EUROASPIRE III Study Stroke Specific Module J Bruthans, O Mayer, J Simon, M Galovcova, J Hrbkova, J Belohoubek, R Cifkova, H Rosolova Institute for Clinical and Experimental Medicine, Prague, Czech Republic, Charles University School of Medicine, Pilsen, Czech Republic Topic: Stroke Aims of study: To assess the prevalence of major risk factors for ischemic stroke, to determine implementation of the secondary prevention of stroke in clinical practice. Methods: A total of 507 consecutive patients aged < 80 years and hospitalized for their first ischemic stroke in the respective district hospital (Praha 4 and Plzen-mesto) were selected retrospectively. Data were obtained from patients hospital medical records and subsequent patients history including the completion of structured questionnaires. Outpatient examination including fasting blood sampling was performed at 636 months post-stroke. The survey was carried out as part of a European study using the protocol of the EUROASPIRE III study Stroke Specific Module. Results: A total of 341 men and women were examined. Of these, at the time of examination, 636 months post stroke, 14.9% were current smokers, 38.8% were obese, 81% had blood pressure levels> 130/80 mmHg, 71.1% had increased LDL-cholesterol (> 2.5 mmol/L), 32.3% had overt diabetes (fasting blood glucose > 7 mmol/L or treatment with oral hypoglycemic agents or insulin), with only 5.5% of patients with diabetes showing satisfactory diabetes control (fasting blood glucose< 6.1 mmol/L). At the time of this examination, 78.9% of patients were receiving antiplatelet drugs or anticoagulants, 52.2% statins, 85.9% antihypertensive medication (43.1% beta-blockers, 68.9% ACE inhibitors or angiotensin II receptor blockers, 39.9% diuretics, and 32.6% calcium-channel blockers). Only a small proportion of patients were compliant with nonpharmacologic measures of secondary prevention (exercise and diet in particular). While signs of depression were possibly or likely present in 33.3% of patients, 21% of patients showed likely or probable anxiety. Conclusion: Secondary preventive lifestyle measures are inadequately implemented, with only a small proportion of patients achieving goal values of risk factors despite widely used drug therapy. The role of post-stroke rehabilitation and psychotherapy is largely underestimated.","PeriodicalId":50492,"journal":{"name":"European Journal of Cardiovascular Prevention & Rehabilitation","volume":"17 1","pages":"S105 - S98"},"PeriodicalIF":0.0000,"publicationDate":"2010-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/17418267100170s230","citationCount":"0","resultStr":"{\"title\":\"Poster Session IV. Epidemiology and public health\",\"authors\":\"Y. Chan, C. Siu, K. Yiu, Sw Li, S. Tam, Th Lam, C. Lau, H. Tse, N. Smeeton, S. Allender, S. Yamada, K. Kamisaka, A. Araki, Y. Fujioka, K. Yasui, Y. Hasegawa, Koike\",\"doi\":\"10.1177/17418267100170s230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"P475 Secondary prevention of stroke in Czech patients in the EUROASPIRE III Study Stroke Specific Module J Bruthans, O Mayer, J Simon, M Galovcova, J Hrbkova, J Belohoubek, R Cifkova, H Rosolova Institute for Clinical and Experimental Medicine, Prague, Czech Republic, Charles University School of Medicine, Pilsen, Czech Republic Topic: Stroke Aims of study: To assess the prevalence of major risk factors for ischemic stroke, to determine implementation of the secondary prevention of stroke in clinical practice. Methods: A total of 507 consecutive patients aged < 80 years and hospitalized for their first ischemic stroke in the respective district hospital (Praha 4 and Plzen-mesto) were selected retrospectively. Data were obtained from patients hospital medical records and subsequent patients history including the completion of structured questionnaires. Outpatient examination including fasting blood sampling was performed at 636 months post-stroke. The survey was carried out as part of a European study using the protocol of the EUROASPIRE III study Stroke Specific Module. Results: A total of 341 men and women were examined. Of these, at the time of examination, 636 months post stroke, 14.9% were current smokers, 38.8% were obese, 81% had blood pressure levels> 130/80 mmHg, 71.1% had increased LDL-cholesterol (> 2.5 mmol/L), 32.3% had overt diabetes (fasting blood glucose > 7 mmol/L or treatment with oral hypoglycemic agents or insulin), with only 5.5% of patients with diabetes showing satisfactory diabetes control (fasting blood glucose< 6.1 mmol/L). At the time of this examination, 78.9% of patients were receiving antiplatelet drugs or anticoagulants, 52.2% statins, 85.9% antihypertensive medication (43.1% beta-blockers, 68.9% ACE inhibitors or angiotensin II receptor blockers, 39.9% diuretics, and 32.6% calcium-channel blockers). Only a small proportion of patients were compliant with nonpharmacologic measures of secondary prevention (exercise and diet in particular). While signs of depression were possibly or likely present in 33.3% of patients, 21% of patients showed likely or probable anxiety. Conclusion: Secondary preventive lifestyle measures are inadequately implemented, with only a small proportion of patients achieving goal values of risk factors despite widely used drug therapy. The role of post-stroke rehabilitation and psychotherapy is largely underestimated.\",\"PeriodicalId\":50492,\"journal\":{\"name\":\"European Journal of Cardiovascular Prevention & Rehabilitation\",\"volume\":\"17 1\",\"pages\":\"S105 - S98\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/17418267100170s230\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cardiovascular Prevention & Rehabilitation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/17418267100170s230\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cardiovascular Prevention & Rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17418267100170s230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
J Bruthans, O Mayer, J Simon, M Galovcova, J Hrbkova, J Belohoubek, R Cifkova, H Rosolova临床和实验医学研究所,布拉格,捷克共和国,查尔斯大学医学院,皮尔森,捷克共和国主题:卒中研究目的:评估缺血性脑卒中主要危险因素的患病率,确定临床实践中脑卒中二级预防的实施情况。方法:回顾性分析在Praha 4区医院和Plzen-mesto区医院连续住院的507例年龄< 80岁的首次缺血性脑卒中患者。数据来自患者的医院医疗记录和随后的患者病史,包括完成结构化问卷。中风后636个月进行门诊检查,包括空腹采血。该调查是一项欧洲研究的一部分,使用EUROASPIRE III研究卒中特定模块的协议。结果:共检查了341名男性和女性。其中,在检查时,中风后636个月,14.9%为吸烟者,38.8%为肥胖,81%血压水平为>30 /80 mmHg, 71.1%低密度脂蛋白胆固醇升高(> 2.5 mmol/L), 32.3%有明显的糖尿病(空腹血糖> 7 mmol/L或口服降糖药或胰岛素治疗),只有5.5%的糖尿病患者表现出满意的糖尿病控制(空腹血糖< 6.1 mmol/L)。在本次检查时,78.9%的患者正在接受抗血小板药物或抗凝血药物,52.2%的他汀类药物,85.9%的抗高血压药物(43.1%的受体阻滞剂,68.9%的ACE抑制剂或血管紧张素II受体阻滞剂,39.9%的利尿剂和32.6%的钙通道阻滞剂)。只有一小部分患者接受了非药物的二级预防措施(尤其是运动和饮食)。33.3%的患者可能或可能出现抑郁症状,21%的患者可能或可能表现出焦虑。结论:二级预防生活方式措施实施不充分,尽管广泛使用药物治疗,但只有一小部分患者达到危险因素目标值。中风后康复和心理治疗的作用在很大程度上被低估了。
P475 Secondary prevention of stroke in Czech patients in the EUROASPIRE III Study Stroke Specific Module J Bruthans, O Mayer, J Simon, M Galovcova, J Hrbkova, J Belohoubek, R Cifkova, H Rosolova Institute for Clinical and Experimental Medicine, Prague, Czech Republic, Charles University School of Medicine, Pilsen, Czech Republic Topic: Stroke Aims of study: To assess the prevalence of major risk factors for ischemic stroke, to determine implementation of the secondary prevention of stroke in clinical practice. Methods: A total of 507 consecutive patients aged < 80 years and hospitalized for their first ischemic stroke in the respective district hospital (Praha 4 and Plzen-mesto) were selected retrospectively. Data were obtained from patients hospital medical records and subsequent patients history including the completion of structured questionnaires. Outpatient examination including fasting blood sampling was performed at 636 months post-stroke. The survey was carried out as part of a European study using the protocol of the EUROASPIRE III study Stroke Specific Module. Results: A total of 341 men and women were examined. Of these, at the time of examination, 636 months post stroke, 14.9% were current smokers, 38.8% were obese, 81% had blood pressure levels> 130/80 mmHg, 71.1% had increased LDL-cholesterol (> 2.5 mmol/L), 32.3% had overt diabetes (fasting blood glucose > 7 mmol/L or treatment with oral hypoglycemic agents or insulin), with only 5.5% of patients with diabetes showing satisfactory diabetes control (fasting blood glucose< 6.1 mmol/L). At the time of this examination, 78.9% of patients were receiving antiplatelet drugs or anticoagulants, 52.2% statins, 85.9% antihypertensive medication (43.1% beta-blockers, 68.9% ACE inhibitors or angiotensin II receptor blockers, 39.9% diuretics, and 32.6% calcium-channel blockers). Only a small proportion of patients were compliant with nonpharmacologic measures of secondary prevention (exercise and diet in particular). While signs of depression were possibly or likely present in 33.3% of patients, 21% of patients showed likely or probable anxiety. Conclusion: Secondary preventive lifestyle measures are inadequately implemented, with only a small proportion of patients achieving goal values of risk factors despite widely used drug therapy. The role of post-stroke rehabilitation and psychotherapy is largely underestimated.